---
layout: minimal
nav_exclude: true
title: Alectinib
---

# Alectinib

**Generic Name:** Alectinib

**Usage:** Alectinib is a tyrosine kinase inhibitor (TKI) primarily used to treat certain types of non-small cell lung cancer (NSCLC).  Specifically, it's used in patients with:

* **ALK-positive NSCLC:** This is its main indication.  It's used as a first-line treatment (the initial treatment) and also as a later-line treatment after other TKIs have been tried.
* **ROS1-positive NSCLC:**  Alectinib can also be used to treat NSCLC driven by ROS1 gene rearrangements.

The specific usage and dosage will be determined by a physician based on the individual patient's condition and medical history.


**Side Effects:** Like all medications, alectinib can cause side effects.  Some common side effects include:

* **Constipation:** This is frequently reported.
* **Nausea and vomiting:** These gastrointestinal issues can be manageable with adjustments to medication or dietary changes.
* **Fatigue:** Feeling tired or lacking energy is a common side effect.
* **Increased liver enzymes:** This requires monitoring through blood tests.
* **Increased creatine kinase:** This indicates potential muscle damage and requires monitoring.
* **Peripheral neuropathy:** Numbness, tingling, or pain in the hands and feet.
* **Vision changes:** Blurred vision or other visual disturbances.
* **Cough:**  Can be both dry and productive.
* **Edema (swelling):**  Can occur in various parts of the body.
* **Pneumonitis (inflammation of the lungs):** A serious side effect requiring immediate medical attention.

This is not an exhaustive list, and the severity and frequency of side effects vary from person to person.  Serious side effects are possible, and patients should report any concerning symptoms to their healthcare provider immediately.


**How it Works:** Alectinib is a highly selective inhibitor of anaplastic lymphoma kinase (ALK) and ROS1 tyrosine kinases.  These kinases are enzymes that play a role in the growth and spread of cancer cells. By inhibiting these kinases, alectinib blocks the signals that promote cancer cell growth and survival, leading to tumor shrinkage or stabilization.


**FAQs:**

* **Q: How is alectinib taken?** A: Alectinib is typically taken orally as a tablet, usually twice a day with food. The specific dosage and frequency will be determined by a physician.

* **Q: What are the long-term effects of alectinib?** A: Long-term effects can vary and require ongoing monitoring by a physician.  Some potential long-term effects may include the persistence of certain side effects or the development of new side effects over time. Regular check-ups and blood tests are crucial.

* **Q: Does alectinib cure cancer?** A: Alectinib is not a cure for cancer, but it can significantly help to control the growth and spread of ALK-positive or ROS1-positive NSCLC.  It aims to prolong life and improve quality of life.

* **Q: What should I do if I miss a dose?** A: Take the missed dose as soon as you remember, unless it is almost time for your next dose.  Never take two doses at once.  Consult your doctor or pharmacist if you have questions about missed doses.

* **Q: Are there any drug interactions with alectinib?** A: Yes, there are potential drug interactions.  It is crucial to inform your doctor and pharmacist about all medications, supplements, and herbal remedies you are taking to avoid potential harmful interactions.


**Disclaimer:** This information is for educational purposes only and should not be considered medical advice.  Always consult with a healthcare professional for any health concerns or before making any decisions related to your health or treatment.  They can provide personalized guidance based on your specific situation.


**Note:** This information is AI-generated or crowd-sourced and may not be accurate. Please consult a medical professional for verified advice.